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Summary It is well known that b-adrenergic receptor activation in parotid acinar cells results
in increased intracellular cAMP levels, and consequently induces exocytotic amylase release.
However, protein kinase C (PKC) has also been considered to contribute to amylase release. In this
paper, we review the role of PKC in cAMP signaling and amylase release. PKCd, a so-called ‘novel
PKC’, has been shown to be activated by b-adrenergic receptor stimulation. Myristoylated
alanine-rich C kinase substrate (MARCKS), a major cellular substrate for PKC, is detected in
parotid acinar cells, and MARCKS phosphorylation and translocation from the membrane to the
cytosol are induced by b-adrenergic receptor stimulation. cAMP-dependent protein kinase (PKA)
inhibitor inhibits b-agonist-induced PKC activation and MARCKS phosphorylation. The b-agonist-
induced amylase release is inhibited by inhibitors of PKCd or by a MARCKS-related peptide. These
findings suggest that MARCKS phosphorylation via PKCd activation, which is downstream of PKA
activation, is involved in the cAMP-dependent amylase release in parotid acinar cells.
# 2009 Japanese Association for Dental Science. Published by Elsevier Ireland. All rights reserved.
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In parotid acinar cells, stimulation of b-adrenergic receptors
induces the exocytotic amylase release [1]. The amylase
release is regulated by intracellular cAMP levels, since ade-
nylate cyclase activators (such as forskolin), cAMP-phospho-
diesterase inhibitors (such as 3-isobutyl-1-methylxanthine)
and cell-permeable forms of cAMP (such as dibutylyl cAMP),
mimic the effects of b-agonist on amylase release [2—4]. The
amylase release occurs without elevation of intracellular
calcium ion (Ca2+) levels, because b-agonists provoke
increases in intracellular cAMP levels, but have no effect
on Ca2+ levels [5,6].* Corresponding author. Tel.: +81 47 360 9325; fax: +81 47 360 9325.
E-mail address: sugiya.hiroshi@nihon-u.ac.jp (H. Sugiya).
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doi:10.1016/j.jdsr.2009.05.002In the cAMP-dependent amylase release, activation of
cAMP-dependent protein kinase (PKA) is thought to be an
essential step in the process. During amylase secretion from
parotid acinar cells, the activity of PKA is enhanced [1]. PKA
inhibitors inhibit the cAMP-dependent amylase release [7,8].
Insertion of PKA induces amylase release in permeabilized
parotid acinar cells [9]. Therefore, it seems likely that PKA
phosphorylates proteins involved in amylase exocytosis. Sev-
eral proteins have been reported to be phosphorylated fol-
lowing b-adrenergic stimulation in parotid glands [10—12].
However, it is not clear which protein is phosphorylated that
is crucial for triggering the cAMP-dependent exocytosis.
On the other hand, it has also been thought that protein
kinase C (PKC) activation is involved in amylase release in
parotid acinar cells based on studies using PKC activators [13—
15]. In this paper, we review the role and importance of PKC on
the cAMP-dependent amylase release in parotid acinar cells.l Science. Published by Elsevier Ireland. All rights reserved.
Figure 1 PKCd activation induced by b-adrenergic receptor
stimulation in parotid acinar cells. Cells were stimulated by the
b-agonist isoproterenol (IPR) for 10 min. p-PKCd in the mem-
brane fraction was detected by Western blotting using an anti-p-
PKCd antibody (upper). PKCd activation is calculated as a ratio
and is normalized against the control at 0 min (lower).
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PKCs comprise a family of phospholipid-dependent enzymes
that catalyze the covalent transfer of phosphate from ATP to
serine and threonine residues of proteins. PKCs are activated
by a variety of extracellular signals and, in turn, modify the
functions of many cellular proteins, including receptors,
enzymes, cytoskeletal proteins and transcription factors.
Phosphorylation of the substrate proteins induces conforma-
tional changes that modify their functional properties.
Therefore, PKCs are involved in a large variety of cell func-
tions and signal transduction pathways that regulate cell
migration and polarity, proliferation, differentiation, ion
fluxes, secretion and cell death [16].
The PKC family consists of at least 10 members, which are
divided into three subgroups based on their structural char-
acteristics and cofactor requirements. They include the
classical cPKC (a, bI, bII and g), the novel nPKC (d, e, h
and u), and the atypical aPKC (z and i/l) isoforms [17,18]. All
isoforms require phosphatidylserine, a component of the
phospholipid bilayer, for their activation. The classical cPKCs
are Ca2+-sensitive and also require diacylglycerol (DAG) or
tumor-promoting phorbol esters for their activation. The
novel nPKCs are Ca2+-independent but still require DAG or
phorbol esters [19]. The atypical aPKCs are also Ca2+-inde-
pendent, and phosphatidylserine is sufficient for their max-
imal activity [20]. Thus, various stimuli can lead to different
responses via isoform-specific PKC signaling regulated by
their expression, localization and phosphorylation status in
particular biological settings.
PKC activity was initially detected in rat parotid gland
[21]. Subsequently, PKCa, d, e and z were found to be
expressed in parotid acinar cells [22,23], and the involve-
ment of PKC in amylase secretion in parotid acinar cells has
been demonstrated [13—15,21,23]. The PKC activator phor-
bol esters, such as phorbol 12,13-dibutyrate and phorbol 12-
myristate 13-acetate (PMA), induce protein secretion in
parotid gland slices [13], and elicit amylase release in parotid
acinar cells [14,15]. It has been shown that phorbol esters
have no effect on adenylate cyclase activity or Ca2+ mobili-
zation [13]. Those observations suggest that PKC contributes
to amylase release in parotid acinar cells. However, the
effects of PKC inhibitors vary; H7 inhibited amylase release
induced by b-adrenergic receptor stimulation [21], whereas
Ro 31-8220 and CGP 41-251 enhances amylase release pro-
voked by norephinephrine [23].
Our current study [24] demonstrated that calphostin C, an
inhibitor of DAG-sensitive PKC [25], partially inhibits amylase
release induced by b-adrenergic receptor stimulation. Since
b-adrenergic receptor activation does not elicit Ca2+ mobi-
lization, this observation suggests that a Ca2+-independent
and DAG-sensitive PKC, i.e. an nPKC such as PKCd, is involved
in amylase release following b-adrenergic receptor stimula-
tion. When the effect of the PKCd-specific inhibitor rottlerin
was examined, that inhibitor mimicked the effect of cal-
phostin C. It is known that activated isoforms of PKC, includ-
ing PKCd, are phosphorylated and translocated from the
cytosol to the cell membrane [26]. In parotid acinar cells
stimulated with a b-agonist (isoproterenol), the amount of
phosphorylated-PKCd in the membrane increased (Fig. 1),
which strongly suggests that b-adrenergic receptor activa-
tion induces PKCd activation in parotid acinar cells. Takentogether, it is most likely that PKCd activated by b-adrenergic
receptor stimulation contributes to amylase release.
3. MARCKS in parotid acinar cells
Dozens of proteins that contain predicted phosphorylation
sites for PKC have been identified. Myristoylated alanine-rich
C kinase substrate (MARCKS) is a major cellular substrate for
PKC [27]. MARCKS binds to the plasmamembrane via the dual
actions of a hydrophobically myristoylated N-terminus and a
polybasic stretch within the so-called effecter domain [28]
which is a phosphorylation site [29]. It is well known that
phosphorylated MARCKS (p-MARCKS) translocates from the
membrane to the cytosol, because phosphorylation of the
effecter domain significantly decreases the binding force of
MARCKS to the membrane [30].
MARCKS has been implicated in various cellular functions
[31,32]. The involvement of MARCKS has been demonstrated
in Ca2+-dependent secretory function. In chromaffin cells,
PMA stimulates noradrenaline release and MARCKS phosphor-
ylation, and a synthetic peptide of the phosphorylation site
domain sequence of MARCKS inhibits the PMA-induced nor-
adrenaline release in permeabilized cells [33,34]. In insulin-
producing INS-1 cells, glucagon-like peptide-1 (GLP-1) sti-
mulates insulin secretion, PKCa and PKCe activation and
MARCKS phosphorylation [35]. A PKC inhibitor inhibits
MARCKS phosphorylation and insulin secretion coupled to
GLP-1-stimulated signaling [35]. Prostaglandin F2a (PGF2a)
stimulates MARCKS phosphorylation and oxytocin secretion in
bovine luteal cells [36]. However, PGF2a failed to stimulate
oxytocin exocytosis in cells expressing a mutant MARCKS
which cannot be phosphorylated by PKC [36]. In SH-SY5Y
human neuroblastoma cells, PMA elicits noradrenaline
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could be abrogated by PKC inhibitors [37]. In BON human
pancreatic carcinoid tumor cells, PMA provokes neurotensin
secretion and MARCKS phosphorylation [38]. A small inter-
fering RNA (siRNA) to MARCKS significantly reduces the PMA-
induced neurotensin secretion, whereas over-expression of
wild-type MARCKS clearly enhances that secretion. Further-
more, siRNAs to PKC inhibit the PMA-induced MARCKS phos-
phorylation [38]. These observations indicate that MARCKS
phosphorylation is involved in Ca2+-dependent secretion. In
NHBE normal human bronchial epithelial cells, a cholinergic
agonist stimulated mucin secretion via cGMP signaling [39]. A
myristoylated N-terminal sequence peptide of MARCKS
(MANS) inhibited mucin secretion induced by 8-bromo-cGMP
with PMA [39] or a cholinergic agonist [40,41]. Therefore, it
has also been suggested that MARCKS phosphorylation is
involved in cGMP-dependent secretion.
Our recent observations demonstrate the involvement of
MARCKS in cAMP signaling in parotid acinar cells [24]. The b-
agonist isoproterenol induces MARCKS phosphorylation in
parotid acinar cells (Fig. 2). Since the adenylate cyclase
activator forskolin and the membrane-permeable cAMP ana-
log dibutyryl-cAMP also induce MARCKS phosphorylation, it is
most likely that MARCKS phosphorylation is cAMP-dependent
in parotid acinar cells. Unphosphorylated MARCKS binds to
the cell membrane but its phosphorylation to p-MARCKS
changes its localization from the membrane to the cytosol
[30]. In fact, the amount of p-MARCKS in the cytosol increases
in parotid acinar cells stimulated with the b-agonist isopro-
terenol (Fig. 3A). Confocal microscopy reveals that MARCKSFigure 2 MARCKS phosphorylation induced by b-adrenergic
receptor stimulation in parotid acinar cells. Cells were stimu-
lated by the b-agonist isoproterenol (IPR) for 10 min. MARCKS
and p-MARCKS in cell lysates were detected by Western blotting
using anti-MARCKS and anti-p-MARCKS antibodies, respectively
(upper). MARCKS phosphorylation is calculated as a ratio of p-
MARCKS/MARCKS and is normalized against the control (lower).in the membrane disappears after stimulation with isopro-
terenol (Fig. 3B). The PKA inhibitor H89 inhibits MARCKS
phosphorylation induced by b-adrenergic receptor stimula-
tion. These observations imply that MARCKS phosphorylation
stimulated by b-adrenergic receptor activation is evoked via
PKA activation in parotid acinar cells.
The relationshipbetweenMARCKSphosphorylationandPKC
activity has beenexamined in parotid acinar cells. Inhibitors of
several isoforms of PKC and of DAG-sensitive PKC (Go¨6983 and
calphostin C, respectively) inhibited MARCKS phosphorylation
induced byb-adrenergic receptor stimulation, but an inhibitor
of Ca2+-dependent PKC (Go¨6976) had no effect. The PKCd-
specific inhibitor rottlerin inhibited MARCKS phosphorylation.
Since PKCd is activated by b-agonists as described above, it is
most likely that the b-agonist-induced MARCKS phosphoryla-
tion is evoked by PKCd activation.
The involvement of MARCKS in the cAMP-dependent amy-
lase release has also been examined in parotid acinar cells
[24]. The N-terminal sequence peptide of MARCKS (MANS),
has been shown to be a useful inhibitor of MARCKS function,
because that peptide suppresses the secretory function of
cultured cells [39] and in vivo [40,41]. In parotid acinar cells
preincubated with the MANS peptide, amylase release
induced by a b-agonist was reduced, suggesting the involve-
ment of MARCKS in amylase release.
4. How does MARCKS function?
We have described here that MARCKS phosphorylation by
PKCd activation is downstream of PKA activation via b-adre-
nergic receptor activation, which is involved in amylase
release in parotid acinar cells. However, it is not yet clear
how p-MARCKS contributes to amylase release. Our hypoth-
esis is that MARCKS is involved in regulating the actin cytos-
keleton, because MARCKS has been proposed to function in
the remodeling of the actin cytoskeleton through direct
binding of F-actin [29]. Phosphorylation at the effecter
domain dissociates MARCKS from F-actin [42], and results
in the loss of actin cross-linking and polymerization activity
[29]. Moreover, a MARCKS effecter domain peptide has also
been shown to induce rapid actin polymerization in vitro [43].
It has also been demonstrated that MARCKS phosphorylation
by PKC causes MARCKS translocation from the membrane to
the cytosol and also interferes with MARCKS binding to F-
actin in some types of cells such as chromaffin cells [33,34],
luteal cells [36] and SH-SY5Y cells [37]. Such a regulation of
the actin cytoskeleton is considered to allow the transloca-
tion of secretory vesicles from the cytosol to the membrane.
In NHBE cells [39], MARCKS has been suggested to function as
a molecular linker by interacting with granule membranes at
its N-terminal domain and binding to actin filaments at its
effecter domain, thus tethering granules to the actin cytos-
keleton allowing their movement and exocytosis.
Regarding the involvement of the actin cytoskeleton in
exocytotic secretory function, regulation of the actin cytos-
keleton structure is considered to be involved in exocytotic
secretory function in chromaffin cells, because the actin
network undergoes reorganization during regulated exocy-
tosis [44]. In parotid acinar cells, since amylase release
induced by b-adrenergic receptor stimulation is inhibited
by the actin filament-disrupting reagent cytochalasin D
[45—47] and by the actin stabilizing reagent jasplakinolide
Figure 3 MARCKS translocation induced by b-adrenergic receptor stimulation in parotid acinar cells. (A) Cells were stimulated by the
b-agonist isoproterenol (IPR) for 10 min. p-MARCKS in the cytosol was detected by Western blotting using an anti-p-MARCKS antibody;
(B) after stimulation, fluorescence was observed using a confocal microscope. Red: MARCKS and actin (a membrane marker) were
visualized by Alexa568 conjugated anti-rabbit IgG and Alexa phalloidin, respectively. Areas in the merged images indicated by the
arrowheads disappeared following b-agonist stimulation. Scale bars equal 10 mm. (For interpretation of the references to color in this
figure legend, the reader is referred to the web version of the article.)
Figure 4 Scheme of the intracellular signaling pathway which
leads to exocytosis induced by b-adrenergic receptor stimulation
through MARCKS phosphorylation due to PKCd activation in
parotid acinar cells.
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to be involved in amylase release. Therefore, it is concei-
vable that MARCKS phosphorylation plays an important role in
the regulation of the actin cytoskeleton in the cAMP-depen-
dent amylase release in parotid acinar cells, although further
studies are needed to fully clarify this.
5. Conclusions
It iswell knownthatb-adrenergic receptor stimulation induces
increases in intracellular cAMP levels, subsequently activates
PKA,which consequently results in exocytotic amylase release
in parotid acinar cells. Our current observations show that PKA
activates PKCd, which is involved in amylase release via
MARCKS phosphorylation (Fig. 4) [24]. This implies crosstalk
between the PKA and PKC signaling pathways. However, it is
not yet clear how PKA activates PKCd in parotid acinar cells.
PKCdhasbeen reported tobe regulatedby severalmechanisms
such as the binding of DAG and the phosphorylation of tyrosine
[48]. In parotid acinar cells, the involvement of phospholipase
D, a DAG producing enzyme, in the cAMP-induced amylase
Role of protein kinase C in cAMP signaling 125release has been reported [49]. Furthermore, tyrosine phos-
phorylation in proteins has been reported to play a role in the
process of amylase exocytosis [50], and therefore, the con-
tribution of these mechanisms to PKCd activation should be
further studied.
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